Cryptococcus gattii infections in multiple states outside the US Pacific Northwest

Emerging Infectious Diseases

Volumn 19, Issue 10, 2013, Pages 1620-1626

  Harris, Julie R ^a   Lockhart, Shawn R ^a   Sondermeyer, Gail ^b   Vugia, Duc J ^b   Crist, Matthew B ^c   D'Angelo, Melissa Tobin ^c   Sellers, Brenda ^d   Franco Paredes, Carlos ^d,e   Makvandi, Monear ^f   Smelser, Chad ^f   Greene, John ^g   Stanek, Danielle ^h   Signs, Kimberly ⁱ   Nett, Randall J ^a,j   Chiller, Tom ^a   Park, Benjamin J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c GEORGIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d PHOEBE PUTNEY MEMORIAL HOSPITAL   (United States)

^e HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^f NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^g H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^h FLORIDA DEPARTMENT OF HEALTH   (United States)

ⁱ MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^j MONTANA DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; FLUCONAZOLE; FLUCYTOSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE CONTROL; FEMALE; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRACRANIAL HYPERTENSION; LEUKOCYTE COUNT; LUMBAR PUNCTURE; LUNG INFECTION; MALE; MULTILOCUS SEQUENCE TYPING; PLEURA EFFUSION; UNITED STATES;

CRYPTOCOCCUS; FUNGAL; FUNGI; GATTII; MENINGITIS; PACIFIC NORTHWEST; PNEUMONIA; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PHYLOGENY; UNITED STATES; YOUNG ADULT;

EID: 84884275012     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1910.130441     Document Type: Article

References (34)

1. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host-and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31:499-508. http://dx.doi.org/10.1086/313992
2. Harris JR, Lockhart SR, Debess E, Marsden-Haug N, Goldoft M, Wohrle R, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis. 2011;53:1188-95. http://dx.doi.org/10.1093/cid/cir723
3. MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol. 2006;44:1851-2. http://dx.doi.org/10.1128JCM.44. 5.1851-1852.2006
4. Georgi A, Schneemann M, Tintelnot K, Calligaris-Maibach RC, Meyer S, Weber R, et al. Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection. 2009;37:370-3. http://dx.doi.org/10.1007/s15010-008-8211-z
5. Galanis E, Macdougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis. 2010;16:251-7. Erratum in: Emerg Infect Dis. 2011;7:1784. Erratum in: Emerg Infect Dis. 2010 16:750.
6. Lalloo D, Fisher D, Naraqi S, Laurenson I, Temu P, Sinha A, et al. Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q J Med. 1994;87:343-9.
7. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995;20:611-6. http://dx.doi.org/10.1093/clinids/20.3.611
8. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28-34. http://dx.doi.org/10.1093/clinids/21.1.28
9. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120:123-30.
10. Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg [A]. 1984;257:213-8.
11. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol. 2001;39:155-68.
12. López-Martínez R, Soto-Hernández JL, Ostrosky-Zeichner L, Castanón-Olivares LR, Angeles-Morales V, Sotelo J. Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia. 1996;134:61-4. http://dx.doi.org/10.1007/BF00436865
13. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291-322. http://dx.doi.org/10.1086/649858
14. Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, Graviss EA, et al. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. J Clin Microbiol. 1996;34:912-7.
15. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis. 2005;11:1686-92. http://dx.doi.org/10.3201/eid1111.040875
16. Byrnes EJ III, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis. 2009;199:1081-6. http://dx.doi.org/10.1086/597306
17. Klein KR, Hall L, Deml SM, Rysavy JM, Wohlfiel SL, Wengenack NL. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. J Clin Microbiol. 2009;47:3669-72. http://dx.doi.org/10.1128/JCM.01072-09
18. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol. 2009;47:561-70. http://dx.doi.org/10.1080/13693780902953886
19. Sellers B, Hall P, Cine-Gowdie S, Hays AL, Patel K, Lockhart SR, et al. Cryptococcus gattii: an emerging fungal pathogen in the southeastern United States. Am J Med Sci. 2012;343:510-1. http://dx.doi. org/10.1097/MAJ.0b013e3182464bc7
20. Walraven CJ, Gerstein W, Hardison SE, Wormley F, Lockhart SR, Harris JR, et al. Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS ONE. 2011;6:e28625. http://dx.doi.org/10.1371/ journal.pone.0028625
21. Kunadharaju R, Choe U, Harris JR, Lockhart SR, Greene JN. Cryptococcus gattii, Florida, USA, 2011. Emerg Infect Dis. 2013;19:519-21. http://dx.doi.org/10.3201/eid1903.121399
22. Sorrell T, Chen SA, Phillips P, Marr K. Clinical perspectives on Cryptococcus neoformans and Cryptococcus gattii: implications for diagnosis and management. In: Heitman J, Kozel TR, Kwon-Chung J, Perfect J, Casadevall A, editors. Cryptococcus: from pathogen to model yeast. Washington (DC): ASM Press; 2011. p. 595-606.
23. Chau TT, Mai NH, Phu NH, Nghia HD, Chuong LV, Sinh DX, et al. A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam-high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis. 2010;10:199. http://dx.doi.org/10.1186/1471-2334-10-199
24. Liao CH, Chi CY, Wang YJ, Tseng SW, Chou CH, Ho CM, et al. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with cryptococcal meningitis. J Microbiol Immunol Infect. 2012;45:296-304. http://dx.doi.org/10.1016/ j.jmii.2011.12.005
25. Ecevit IZ, Clancy CJ, Schmalfuss IM, Nguyen MH. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis. 2006;42:1443-7. http://dx.doi.org/10.1086/503570
26. Einsiedel L, Gordon DL, Dyer JR. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis. 2004;39:e78-82. http://dx.doi.org/10.1086/424746
27. Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, et al. Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99:143-51. http://dx.doi.org/10.1093/qjmed/hcl014
28. Lane M, McBride J, Archer J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis. Neurology. 2004;63:713-4. http://dx.doi.org/10.1212/01. WNL.0000134677.29120.62
29. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell DA. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg. 1997;91:50-2. http://dx.doi.org/10.1016/S0035-9203(97)90393-X
30. Day JN, Hoang TN, Duong AV, Hong CT, Diep PT, Campbell JI, et al. Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol. 2011;49:658-64. http://dx.doi.org/10.1128/ JCM.01985-10
31. Varma A, Swinne D, Staib F, Bennett JE, Kwon-Chung KJ. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol. 1995;33:1807-14.
32. Johannson KA, Huston SM, Mody CH, Davidson W. Unique features of Cryptococcus gattii pneumonia-a prolonged incubation period in an immunocompetent host. Am J Respir Crit Care Med. 2011.
33. Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol. 1977;105:582-6.
34. Denton JF, Di Salvo AF. The prevalence of Cryptococcus neoformans in various natural habitats. Sabouraudia. 1968;6:213-7.